Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Walter

Showing results (1-10 of 333) with videos related to

Pageof 34
Sort By:
Endoscopy International Open|February 13, 2019
No histology for diminutive duodenal neuroendocrine tumors: Is it safe?Thomas Walter
The Lancet. Oncology|August 26, 2017
Maintaining quality of life for patients with neuroendocrine tumoursThomas Walter
Endoscopy International Open|June 15, 2019
Endoscopic removal of colorectal T1 cancers: Why is a 1-year follow-up recommended by ESGE when resection is R0 and curative?Mathieu Pioche, Thomas Walter
The Protein Journal|May 5, 2019
Current Advances in Protein Import into PeroxisomesThomas Walter, Ralf Erdmann
Lancet (London, England)|August 2, 2016
Everolimus in ileum neuroendocrine tumoursThomas Walter, Catherine Lombard-Bohas
Neuroendocrinology|March 15, 2012
Quality of clinical trials in gastroenteropancreatic neuroendocrine tumoursThomas Walter, Monika K Krzyzanowska
The Journal of Dermatology|June 5, 2026
Broadening the View: Substance P and Its Metabolism in Pruritus-Related DiseasesThomas Walter, Bjoern B Burckhardt
The Oncologist|March 11, 2017
In ReplyRomain Coriat, Benoît Terris, Thomas Walter
European Journal of Endocrinology|October 25, 2013
Endocrine side effects of anti-cancer drugs: effects of anti-cancer targeted therapies on lipid and glucose metabolismBruno Vergès, Thomas Walter, Bertrand Cariou
Gastrointestinal Endoscopy|November 17, 2023
EUS-guided radiofrequency ablation of pancreatic neoplasm is far from being the new criterion standardMilenea Muzzolini, Thomas Walter, Sébastien Gaujoux
Pageof 34

Showing results (1-10 of 333) with videos related to

Sort By:
Pageof 34
Endoscopy International Open|February 13, 2019
No histology for diminutive duodenal neuroendocrine tumors: Is it safe?Thomas Walter
The Lancet. Oncology|August 26, 2017
Maintaining quality of life for patients with neuroendocrine tumoursThomas Walter
Endoscopy International Open|June 15, 2019
Endoscopic removal of colorectal T1 cancers: Why is a 1-year follow-up recommended by ESGE when resection is R0 and curative?Mathieu Pioche, Thomas Walter
The Protein Journal|May 5, 2019
Current Advances in Protein Import into PeroxisomesThomas Walter, Ralf Erdmann
Lancet (London, England)|August 2, 2016
Everolimus in ileum neuroendocrine tumoursThomas Walter, Catherine Lombard-Bohas
Neuroendocrinology|March 15, 2012
Quality of clinical trials in gastroenteropancreatic neuroendocrine tumoursThomas Walter, Monika K Krzyzanowska
The Journal of Dermatology|June 5, 2026
Broadening the View: Substance P and Its Metabolism in Pruritus-Related DiseasesThomas Walter, Bjoern B Burckhardt
The Oncologist|March 11, 2017
In ReplyRomain Coriat, Benoît Terris, Thomas Walter
European Journal of Endocrinology|October 25, 2013
Endocrine side effects of anti-cancer drugs: effects of anti-cancer targeted therapies on lipid and glucose metabolismBruno Vergès, Thomas Walter, Bertrand Cariou
Gastrointestinal Endoscopy|November 17, 2023
EUS-guided radiofrequency ablation of pancreatic neoplasm is far from being the new criterion standardMilenea Muzzolini, Thomas Walter, Sébastien Gaujoux
Pageof 34